PHARMANUTRA S.P.A.: NEW DISTRIBUTION AGREEMENTS IN

INDONESIA, KUWAIT AND MEXICO

PT Pyridam Farma Tbk., PharmaLife Co. and SMS Pharma will introduce SiderAL® and Cetilar® merchandise within the Indonesian, Kuwaiti and Mexican markets, therefore increasing the presence of PharmaNutra applied sciences in South-East Asia, the Arabian Peninsula and Central America.

Pisa, 4 January 2023 – PharmaNutra S.p.A.(MTA; Ticker PHN), an organization specialised in mineral and iron- primarily based dietary dietary supplements and medical units for muscular tissues and joints well being, is happy to announce the signing of three new worldwide commerce agreements for the distribution of its SiderAL® and Cetilar® strains within the Republic of Indonesia, Kuwait and Mexico.

So far as Indonesia is worried, the brand new associate PT Pyridam Farma Tbk. will distribute two dietary dietary supplements containing Sucrosomial® Iron, SiderAL® F30 (PharmaNutra model) and SiderAL® Gocce P (Junia Pharma model). These merchandise, the previous meant for an grownup goal and the latter for the paediatric sector, will develop into a part of the Pyridam Farma portfolio, which incorporates worldwide merchandise of firms of the calibre of Eli Lilly, Amgen, Astra Zeneca and Lundbeck. As a matter of truth, the corporate has operated within the Indonesian pharmaceutical sector for greater than 40 years and, due to its community of greater than 320 medical science liaisons, its manufacturing and advertising and marketing actions cowl all 34 of the nation’s provinces, with a possible usership of 275 million inhabitants (the Republic of Indonesia has the fourth highest inhabitants on the earth, after China, India and USA).

As regards Kuwait, the settlement was concluded with PharmaLife Co., an organization that distributes medical units, meals dietary supplements, medical tools and pure merchandise and is already associate to vital Italian and international firms. The settlement is especially related as a result of, regardless of working in a smaller territorial context than Indonesian big Pyridam Farma, PharmaLife Co. will likely be putting 5 PharmaNutra merchandise and one Junia Pharma product in the marketplace, particularly: Cetilar®

Cream, Cetilar® Patch, SiderAL® Folic 20 sticks, SiderAL® Folic 30 cps, SiderAL® Forte Int 20 cps and SiderAL® Gocce P.

In Mexico, PharmaNutra has finalised a brand new partnership with the corporate SMS Pharma, whose core enterprise focuses on creating nationwide gross sales networks specialising within the distribution of pharmaceutical

and well being merchandise. The contract with SMS Pharma will consequence, in the middle of 2023, within the advertising and marketing of the dietary dietary supplements SiderAL® Forte 15 mg 30 cps and SiderAL® Folic 21 mg 20 sticks (PharmaNutra), in addition to SiderAL® Gocce P (Junia Pharma) all through Mexico.

With the conclusion of those new distribution agreements, the PharmaNutra Group can now depend on 47 distributors in 70 nations throughout Europe, Asia, Latin America and Africa.

“Following the distribution agreements in Denmark and Albania regarding SiderAL® merchandise, it’s a pleasure to announce the beginning of three new partnerships of strategic significance, inside the scope of the PharmaNutra Group’s worldwide growth agenda”, states Carlo Volpi, COO of the PharmaNutra Group. “Indonesia is a market with big potential, the nation with the fourth largest inhabitants on the earth: it has been an extended journey, however we are actually able to reap the rewards of the excellent work accomplished by our Worldwide Enterprise Growth crew. As regards Kuwait and Mexico, though the nation dimension is completely different, the agreements are significantly important from the attitude of business positioning, as they make provision for the distribution of our two main product households, SiderAL® and Cetilar®, and due to this fact we’re significantly optimistic concerning future developments in these nations.”

PharmaNutra S.p.A.

Based and led by Chairman Andrea Lacorte and Deputy Chairman Roberto Lacorte, PharmaNutra is an organization established in 2003 that develops distinctive meals dietary supplements and revolutionary diet units by finishing up your entire manufacturing course of, from the proprietary beginning supplies by way of to the completed product. The effectiveness of its merchandise is demonstrated by a wealth of scientific proof, together with 135 publications involving greater than 7000 topics. The Group distributes and locations its merchandise in the marketplace in Italy and overseas. Inside Italy, gross sales actions are carried out by way of a community of over 160 medical science liaisons serving the medical career, in addition to specializing in the unique advertising and marketing of PharmaNutra merchandise to pharmacies all through the nation. Gross sales actions are assured overseas in 70 completely different nations by way of 47 companions chosen amongst one of the best pharmaceutical firms. PharmaNutra is a market chief within the manufacture of dietary dietary supplements containing iron with its SiderAL® model, the place it boasts vital patents overlaying its Sucrosomial® Expertise. Through the years, the Group has developed a exact technique concerning the administration and manufacturing of mental property, primarily based on built-in administration of all the varied elements: proprietary beginning supplies, patents, manufacturers and scientific proof.

PharmaNutra.it